Viseon Spine Closes $18 Million Series B Financing

Represented Viseon Spine in its $18 million Series B venture funding in a deal co-led by Invus Financial Advisors, Wexford Capital and HBM-MedFocus Fund. Viseon, Inc. is a developer and manufacturer of a medical device intended to improve the procedural and clinical outcomes of minimally invasive spine surgery procedures. Viseon was spun-off from Rebound Therapeutics Corporation in 2017 and is a medical device company committed to developing proprietary state-of-the-art visualization and illumination technologies for use in Minimally Invasive Spine Surgery (MISS) procedures.